Boston Scientific Corp., which last quarter reported that its share in the stent market was slipping, said Thursday that it expects to hold its ground in the third quarter of 2005.
http://c.moreover.com/click/here.pl?r406514153
http://c.moreover.com/click/here.pl?r406514153